Echocardiography and Peak Endocardial Acceleration (PEA) Measurements in Cardiac Resynchronization Therapy (CRT)
NCT ID: NCT01066078
Last Updated: 2010-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
216 participants
OBSERVATIONAL
2007-10-31
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Echocardiography in Cardiac Resynchronization Therapy (Echo-CRT)
NCT02986633
Impact of Intraventricular Electrical Activation in Resynchronization Therapy
NCT01270646
Comparison of Cardiac Resynchronisation Therapy (CRT) Response Using High Frequency (HF) - ECG or Q-LV Guided Optimisation for Left Ventricular, Pacing Site.
NCT05829876
Comparability of Hemodynamic Parameters Measured by Non-invasive Echocardiography and by Right Heart Catheterization
NCT03231774
Harnessing ECG Artificial Intelligence for Rapid Treatment and Accurate Identification of Structural Heart Disease
NCT06462989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CRT recipients
Echocardiography and SonR recording
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Echocardiography and SonR recording
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Minor patient or pregnant woman.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LivaNova
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
CCP, CHU Pontchaillou 35033 RENNES France
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erwan DONAL, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Rennes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nouvelles Cliniques Nantaises
Nantes, , France
Clinique Bizet
Paris, , France
CHU Pontchaillou
Rennes, , France
CHU Rennes
Rennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RGEA01
Identifier Type: -
Identifier Source: secondary_id
RGEA01 - CAP PEA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.